Hao Chen

Title: Hao Chen - Innovator in Pharmaceutical Composition

Introduction

Hao Chen is a notable inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable compositions for therapeutic use. His work focuses on enhancing the efficacy and stability of medications, which is crucial for patient care.

Latest Patents

Hao Chen holds a patent for a "Stable rasagiline composition." This invention provides a stable formulation of rasagiline, which includes an effective dosage of the drug or its pharmaceutically acceptable salts, along with an antioxidant used as a stabilizer. The composition is designed for various transdermal and mucoadhesive drug delivery systems, such as patches, gels, ointments, creams, cataplasms, films, sprays, and solutions. This innovative composition can be utilized to prevent or treat mental disorders, showcasing its potential impact on healthcare.

Career Highlights

Throughout his career, Hao Chen has worked with prominent organizations, including the Chongqing Pharmaceutical Research Institute Co., Ltd. and the Chongqing Pharmaceutical Industrial Research Institute Co. Ltd. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Hao Chen has collaborated with esteemed colleagues, including Jialiang Lin and Jie Deng. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Hao Chen's contributions to pharmaceutical compositions, particularly his stable rasagiline formulation, highlight his role as an innovator in the industry. His work not only advances medical science but also has the potential to improve the quality of life for patients suffering from mental disorders.